Meet the shortlist: Company of the Year

The third annual Femtech World Awards ceremony is almost here. And today, we’re excited to reveal the shortlist for Company of the Year, sponsored by Femovate.

This award exists to recognise a company that doesn’t just build a product, but shifts the entire landscape of women’s health.

The winner will be an organisation that has demonstrated exceptional leadership in addressing women’s health needs through groundbreaking products, services, or platforms – one that is not only advancing care today but actively shaping the future of global femtech.

Femovate, our sponsor for this category, knows this territory well.

As the global femtech incubator and a true catalyst for change in women’s health, Femovate uses design to fuel innovation across every stage of a woman’s health journey,  from proactive prevention to early detection and personalised treatment.

With over US$2 million in design capital invested, 30 products launched, and 7 FDA clearances supported across their portfolio, they are uniquely placed to champion the kind of bold, rigorous company-building this award celebrates.

Congratulations to the shortlist and thank you to everyone who entered or nominated.

Company of the Year Shortlist

Founded by physicist Dr Elina Berglund Scherwitzl, Co-Founder and CEO, Natural Cycles created the world’s first FDA-cleared and CE-marked contraceptive app, establishing digital contraception as a credible and regulated category in women’s healthcare.

Achieving these clearances required extensive clinical trials and rigorous scientific validation, setting a new benchmark for digital products in the femtech space.

In doing so, Natural Cycles helped define the regulatory pathway for the industry — meaning any company looking to develop digital contraceptives today must meet the same high scientific and regulatory standards that Natural Cycles pioneered.

ŌURA, the creator of Oura Ring, stands at the forefront of global femtech, redefining how women understand and manage their health through continuous innovation, research, and responsible AI.

Oura exemplifies what it means to drive meaningful impact in a historically underserved space by delivering personalised insights across women’s health – from menstruation, to pregnancy, perimenopause, and beyond.

That leadership is visible across ŌURA’s growing women’s health ecosystem. Features such as Cycle Insights, Period Prediction, Fertile Window, and Pregnancy Insights are designed to help women interpret changes across different life stages using continuous signals including temperature trends, sleep, stress, activity, and recovery.

Rather than offering one-size-fits-all tracking, ŌURA brings context to the complexity of women’s physiology—helping members see how hormonal shifts can shape readiness, sleep quality, recovery, and daily wellbeing.

Youterus Health is transforming how uterine health is understood, diagnosed, and treated across underserved markets.

Operating at the intersection of research, technology, and care delivery, the company has built an integrated platform that converts women’s lived experiences into structured health data, enabling earlier diagnosis, improved care pathways, and more equitable access to treatment,

At the core of this innovation is the WOMB Index—a first-of-its-kind, narrative-based diagnostic tool that captures both quantitative and experiential data on uterine health conditions such as fibroids, endometriosis, and heavy menstrual bleeding.

This is complemented by an AI-enabled platform that supports multilingual data collection, real-time symptom tagging, and population-level insights, creating a new standard for how women’s health data is generated and used.